Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × ibrutinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 46 Lymphoma, Mantle-Cell 22 Lymphoma, Non-Hodgkin 15 Lymphoma, Large B-Cell, Diffuse 13 Lymphoma, Follicular 11 Waldenstrom Macroglobulinemia 10 Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 8 Recurrence 7 Neoplasms 6 Leukemia 6 Lymphoma, B-Cell 4 Leukemia, B-Cell 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Multiple Myeloma 2 Melanoma 2 Leukemia, Prolymphocytic 2 Leukemia, Lymphoid 2 Leukemia, Hairy Cell 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Glioblastoma 2 Burkitt Lymphoma 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Primary Central Nervous System Lymphoma (PCNSL) 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurologic Manifestations 1 Neuroectodermal Tumors, Primitive 1

Interventions

Cisplatin 3 capivasertib 2 Radiosurgery 2 Nivolumab 2 Carboplatin 2 tivozanib 1 pazopanib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 abexinostat 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡